Tysabri (Natalizumab)

Tysabri is a monoclonal antibody prescription medication used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Tysabri infusions for MS are aimed at slowing the progression of the disease; as such, they can be an effective part of an overall MS treatment plan.

Tysabri is also used to treat moderate to severe Chron’s disease.

https://www.tysabri.com

Indication:

• Multiple Sclerosis

• Chron’s Disease

Infusion Duration:

1-hour (Additional observation period required upon initiation of therapy)

Frequency:

• Every 4-6 weeks